Precipio Net Income 2012-2025 | PRPO
Precipio net income from 2012 to 2025. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
|
Precipio Annual Net Income (Millions of US $) |
|
|---|---|
| 2024 | $-4 |
| 2023 | $-6 |
| 2022 | $-12 |
| 2021 | $-9 |
| 2020 | $-14 |
| 2019 | $-13 |
| 2018 | $-20 |
| 2017 | $-33 |
| 2016 | $-4 |
| 2015 | $-34 |
| 2014 | $-15 |
| 2013 | $-17 |
| 2012 | $-9 |
| 2011 | $-11 |
|
Precipio Quarterly Net Income (Millions of US $) |
|
|---|---|
| 2025-09-30 | $0 |
| 2025-06-30 | $0 |
| 2025-03-31 | $-1 |
| 2024-12-31 | $0 |
| 2024-09-30 | $-1 |
| 2024-06-30 | $-1 |
| 2024-03-31 | $-2 |
| 2023-12-31 | $1 |
| 2023-09-30 | $-1 |
| 2023-06-30 | $-2 |
| 2023-03-31 | $-3 |
| 2022-12-31 | $-2 |
| 2022-09-30 | $-3 |
| 2022-06-30 | $-2 |
| 2022-03-31 | $-5 |
| 2021-12-31 | $-2 |
| 2021-09-30 | $-2 |
| 2021-06-30 | $-3 |
| 2021-03-31 | $-1 |
| 2020-12-31 | $-2 |
| 2020-09-30 | $-3 |
| 2020-06-30 | $-2 |
| 2020-03-31 | $-7 |
| 2019-12-31 | $-4 |
| 2019-09-30 | $-2 |
| 2019-06-30 | $-6 |
| 2019-03-31 | $-2 |
| 2018-12-31 | $-7 |
| 2018-09-30 | $-4 |
| 2018-06-30 | $-3 |
| 2018-03-31 | $-6 |
| 2017-12-31 | $-13 |
| 2017-09-30 | $-10 |
| 2017-06-30 | $-9 |
| 2017-03-31 | $-1 |
| 2016-12-31 | $1 |
| 2016-09-30 | $0 |
| 2016-06-30 | $0 |
| 2016-03-31 | $-4 |
| 2015-12-31 | $-20 |
| 2015-09-30 | $-8 |
| 2015-06-30 | $-3 |
| 2015-03-31 | $-3 |
| 2014-12-31 | $-6 |
| 2014-09-30 | $0 |
| 2014-06-30 | $-4 |
| 2014-03-31 | $-4 |
| 2013-12-31 | $-4 |
| 2013-09-30 | $-6 |
| 2013-06-30 | $-3 |
| 2013-03-31 | $-4 |
| 2012-12-31 | $-2 |
| 2012-09-30 | $-3 |
| 2012-06-30 | $-1 |
| 2012-03-31 | $-3 |
| 2011-12-31 | $0 |
| 2011-09-30 | $-2 |
| 2011-06-30 | $-6 |
| 2011-03-31 | $-3 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.038B | $0.019B |
| Precipio Inc. has built a platform designed to eradicate the problem of misdiagnosis by harnessing the intellect, expertise and technology developed within academic institutions and delivering quality diagnostic information to physicians and their patients worldwide. Through its collaborations with world-class academic institutions specializing in cancer research, diagnostics and treatment, Precipio offers a new standard of diagnostic accuracy enabling the highest level of patient care. Precipio Inc., formerly known as Transgenomic Inc., is based in Omaha, United States of America. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $29.102B | 33.66 |
| Tempus AI (TEM) | United States | $9.538B | 0.00 |
| IRhythm Holdings (IRTC) | United States | $4.901B | 0.00 |
| Doximity (DOCS) | United States | $4.888B | 20.77 |
| Hims & Hers Health (HIMS) | United States | $3.799B | 30.91 |
| Hinge Health (HNGE) | United States | $3.051B | 0.00 |
| Privia Health (PRVA) | United States | $2.657B | 166.15 |
| 10x Genomics (TXG) | United States | $2.423B | 0.00 |
| Heartflow (HTFL) | United States | $2.295B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $1.982B | 26.44 |
| Omnicell (OMCL) | United States | $1.697B | 47.28 |
| Azenta (AZTA) | United States | $1.403B | 56.39 |
| Enovis (ENOV) | United States | $1.304B | 6.85 |
| Clover Health Investments (CLOV) | United States | $1.059B | 0.00 |
| Schrodinger (SDGR) | United States | $0.883B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.829B | 0.00 |
| Phreesia (PHR) | United States | $0.754B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.711B | 0.00 |
| Talkspace (TALK) | United States | $0.654B | 131.67 |
| Standard BioTools (LAB) | United States | $0.458B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.348B | 0.00 |
| Claritev (CTEV) | United States | $0.343B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.323B | 0.00 |
| Senseonics Holdings (SENS) | United States | $0.315B | 0.00 |
| Carlsmed (CARL) | United States | $0.304B | 0.00 |
| Evolent Health (EVH) | United States | $0.298B | 0.00 |
| TruBridge (TBRG) | United States | $0.280B | 12.85 |
| CapsoVision (CV) | United States | $0.226B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.211B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.168B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.164B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.159B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.141B | 0.00 |
| CareCloud (CCLD) | United States | $0.095B | 5.21 |
| Outset Medical (OM) | United States | $0.082B | 0.00 |
| American Well (AMWL) | United States | $0.071B | 0.00 |
| 111 (YI) | China | $0.068B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.067B | 0.00 |
| Pulmonx (LUNG) | United States | $0.060B | 0.00 |
| HeartBeam (BEAT) | United States | $0.053B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.033B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.028B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.020B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.019B | 0.00 |
| Movano (MOVE) | United States | $0.015B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.015B | 0.00 |
| HeartSciences (HSCS) | United States | $0.010B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.007B | 0.00 |
| ITonic Holdings (ITOC) | China | $0.007B | 0.00 |
| Zhongchao (ZCMD) | China | $0.006B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.005B | 0.00 |
| PROFUSA (PFSA) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.001B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.001B | 0.00 |